The challenge to diagnose and treat cognitive decline in our growing aging population is great. Alzheimer’s diagnosis in the US is predicted to soar (to 13.8 million in 2060, up from 6.2 million in 2021)—and so are nationwide shortages of specialists, including geriatricians and neurologists. This one-two punch puts pressure on primary care physicians (PCPs), […]
Read more
With almost 50 million people worldwide affected by dementia—and Alzheimer’s disease the likely cause in 60% to 80% of these cases—detection and care is at a critical juncture. Despite high prevalence of cognitive disease, significant barriers, healthcare provider burnout, and systemic bottlenecks all interfere with their identification and treatment. By exploring common problems in cognitive […]
Read more